Titan Pharmaceuticals Inc

CIK 910267 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Titan Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Nov 14, 2025EFFECT9999999995-25-003275
Nov 14, 2025EFFECT9999999995-25-003281
Nov 14, 2025EFFECT9999999995-25-003279
Nov 14, 2025EFFECT9999999995-25-003285
Nov 14, 2025EFFECT9999999995-25-003280
Nov 14, 2025EFFECT9999999995-25-003277
Oct 14, 202515-12G0001829126-25-008099
Oct 9, 2025S-8 POS0001829126-25-008009
Oct 9, 2025POS AM0001829126-25-007999
Oct 9, 2025POS AM0001829126-25-008002
Oct 9, 2025POS AM0001829126-25-008005
Oct 9, 2025S-8 POS0001829126-25-008006
Oct 9, 2025POS AM0001829126-25-007997
Oct 9, 2025S-8 POS0001829126-25-008004
Oct 9, 2025POS AM0001829126-25-008008
Oct 9, 2025POS AM0001829126-25-008007
Oct 9, 2025POS AM0001829126-25-008003
Oct 8, 202540000921895-25-002721
Oct 2, 202525-NSE0001354457-25-000977
Oct 1, 20258-K0001829126-25-007823
Aug 26, 20258-K0001829126-25-006734
Aug 22, 2025DEFA14A0001641172-25-025165
Aug 14, 2025DEFA14A0001641172-25-024185
Aug 14, 202510-Q0001829126-25-006318
Jul 22, 2025DEFA14A0001641172-25-020611